Key result
Lifelong CV health promotion is required to sustain reductions in disease burden and healthcare costs.
Why the study?
Cardiovascular disease remains the leading cause of U.S. mortality with escalating costs driven by a focus on treating disease rather than promoting health, necessitating a shift toward health promotion.
Emphasizes the need for a paradigm shift from treating cardiovascular disease to promoting cardiovascular health throughout the life course to reduce mortality and healthcare costs.
Answers are grounded in this paper and cite their sources.
Highlights urgent need to prioritize prevention over treatment; leaves open optimal strategies for population-level impact.
Despite numerous groundbreaking advances in the field, cardiovascular disease remains the leading cause of mortality in the United States, accounting for more than 787,000 deaths per year. Already leading the world in per capita healthcare expenditure, U.S. medical costs related to cardiovascular disease are projected to triple by 2030, to over $800 billion annually. The medical community's traditional disproportionate focus on treating cardiovascular disease, relative to promoting cardiovascular health, is an important contributor to these expenses. To ensure continued reductions in the burden of cardiovascular disease, as well as the overall sustainability of the healthcare system, a paradigm shift that places more emphasis on cardiovascular health promotion throughout the life course is required. This review will discuss the current definitions of cardiovascular health, as well as strategies for promoting and impacting cardiovascular health at both the local and national level.
No takes yet. Share an insight, caveat, or question.
Knapper et al. (2015) conducted a review in Cardiovascular disease. Cardiovascular health promotion was evaluated. A paradigm shift placing more emphasis on cardiovascular health promotion throughout the life course is required to ensure continued reductions in cardiovascular disease burden and healthcare costs.
Synapse has enriched 10 related papers. Consider them for comparative context: